Atlas Trials

Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization

Clinical trial NCT03805178 · WITHDRAWN

Trial details

NCT number
NCT03805178
Sponsor
Duke University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Transplant RejectionAntibody-mediated Rejection
Start date
2019-05-01
Primary completion
2020-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.